Background: Cholesterol crystals are involved in various chronic inflammatory diseases; however, direct pattern recognition receptors (PRRs) recognizing cholesterol crystals have not been identified. Results: We purified endogenous components interacting with human Mincle and identified cholesterol. Conclusion: Direct interaction of human Mincle with cholesterol crystals activates innate immune responses. Significance: Human Mincle could be a therapeutic target of chronic inflammation.
nized that excessive intake of cholesterol leads to hypercholesterolemia and results in the formation of cholesterol crystals (12, 13) . Cholesterol crystals are present in atherosclerotic plaques and are released into blood upon plaque rupture. The most serious symptoms triggered by the crystals have long been considered to be the formation of embolus in small vessels, causing ischemia and inflammation (14) . Although cholesterol crystal deposition was previously considered to be a feature of advanced atherosclerosis, a recent study shows that cholesterol crystals are present in early atherosclerotic lesions (15) . In addition, they can directly trigger inflammatory responses by inducing IL-1␤ and IL-1␣ through the activation of NLRP3 inflammasomes (15) (16) (17) (18) . As such, cholesterol crystals have been recently defined to be one of DAMPs (14, 15, 19) . However, the direct recognition of cholesterol crystals by PRRs is not fully understood, although several proteins are reported to interact with cholesterol (20 -23) . In this study, we identify cholesterol crystals as endogenous ligands for hMincle and find that this interaction activates myeloid cells to produce pro-inflammatory molecules.
Experimental Procedures
Reagents-Cholesterol (C75209), cortisone (C2755), progesterone (P8783), estradiol (E8875), Testosterone (T1500), aldosterone (A9477), ergosterol (E5610), TDM (T3034), and LPS (L4516) were purchased from Sigma-Aldrich. Total lipid extract from bovine liver (181104C), dehydroepiandrosterone (DHEA) (700087P), cholesteryl ester 14:0 (110859P), 16 :0 (110862P), 18:0 (110866P), 20:0 (110870P), and 22:0 (110875P), sitosterol (700095P), desmosterol (700060P), and cholestanoic acid (700070P) were purchased from Avanti. The Screen-Well Fatty Acid Library BML-2803 Version 1.0 was purchased from Enzo Life Sciences. 1-(Trimethylsilyl) imidazole was obtained from Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan). Monosodium urate crystals were purchased from InvivoGen. Cholesterol crystals were prepared as described previously (16) . Briefly, cholesterol dissolved in 95% ethanol was heated to 60°C and then left at room temperature to form crystals. Cholesterol crystals were suspended in PBS.
Cells-2B4-NFAT-GFP reporter cells expressing various C-type lectin receptors were prepared as described previously (8) . For FcR␥-coupled receptors, the reporter cells expressing FcR␥ alone were used as control. RAW-Blue cells were purchased from InvivoGen and were further transfected with hMincle using retrovirus-mediated gene transfer (pMX-IREShCD8). For preparation of human monocyte-derived DCs, human peripheral blood mononuclear cells were isolated from peripheral blood of healthy donors by Lymphocyte Separation Solution (d ϭ 1.077) (Nacalai Tesque) gradient centrifugation. Human CD14 ϩ monocytes were purified from peripheral blood mononuclear cells using anti-human CD14 MicroBeads (Miltenyi Biotec, Bergisch Gladbach, Germany). Dendritic cells were obtained from CD14 ϩ monocytes after culture in RPMI 1640 supplemented with 10% FBS, non-essential amino acid, 10 ng/ml human GM-CSF, and 10 ng/ml human IL-4 for 7 days. For cell stimulation, lipid ligands were solubilized in chloroform:methanol (C:M), diluted with 2-propanol, and used as plate-coated form.
Preparation of Lipophilic Fraction-Bovine liver was treated with C:M (2:1, v/v), and soluble extract was further fractionated by high performance thin-layer chromatography (HPTLC). Each fraction was collected from the TLC plate and dissolved in C:M, followed by dilution with 2-propanol for cell stimulation.
In Vitro Stimulation Assay-Each 2-propanol-diluted lipid was added at 20 l to a well of a 96-well plate followed by evaporation of the solvent as described previously (9) . For Ab blocking, cells were stimulated with cholesterol crystals or the plate-coated form of various lipids for 18 -24 h in the presence or absence of anti-human Mincle mAb 13D10-H11 (rat IgG1, ) (24). Isotype-matched control mAb (clone, R3-34) was purchased from BD Biosciences. Reporter activity was determined by flow cytometry (2B4-NFAT-GFP cells). Concentration of murine TNF and human IL-1␤ was measured by the ELISA kit (BD Pharmingen).
Identification of Cholesterol-Fraction #7-15 was subjected to normal-phase HPLC (column, Cosmosil 5SLII; mobile phase, n-hexane/2-propanol (99/1); detection, 210 ), and the peak was identified to represent cholesterol based on the result of the subsequent mass analysis (micrOTOF II, Bruker). Cholesterol in Fraction #7-15: t R (min) ϭ 8.95, m/z ϭ 409.3318 [MϩNa] ϩ , calculated for C 27 H 46 NaO, ⌬ milli mass unit (mmu) ϭ 12.3. Standard cholesterol: t R (min) ϭ 8.92, m/z ϭ 409.3394 [MϩNa] ϩ , ⌬mmu ϭ 4.7. The GC-MS analysis of the trimethylsilyl (TMS) sterols was undertaken using a Shimadzu QP-2010 GC-MS system (Kyoto, Japan), operating in electron ionization mode with an ionization energy of 70 eV. The instrument was equipped with an INERTCAP-5MS/SIL capillary column (30 m, inner diameter 0.25 mm, GL Sciences, Tokyo, Japan) with helium as carrier gas at a 0.66 ml/min flow rate. Column temperature was initially kept for 2 min at 250°C, gradually increased to 280°C at a rate of 5.0°C/min, and then increased to 280°C and kept for 20 min. The injector and interface were set to 300 and 250°C, respectively. The gas chromatograph operated in the split-less mode. The mass spectrum was monitored starting at m/z 40 and ending at m/z 600, with a scan interval of 1.0 s and a threshold of 1000, and the solvent cut was set to 2 min. The sterol sample was heated with 1-(trimethylsilyl) imidazole (Tokyo Chemical Industry Co., Ltd.)/pyridine (1/1, 0.1 ml) for 1 h at 60°C to give the TMS ether of sterol. The injection solution (1 ml) was TMS sterols in n-hexane.
Ig Fusion Protein-The extracellular domain of human Mincle (amino acids 46 -219) was fused to the hIgG1 Fc region and prepared as described previously (10). 
In Vitro Mincle Binding Assay-2 g/ml hIgG1-Fc (Ig) and hMincle-Ig in binding buffer (20 mM Tris-HCl, 150 mM NaCl, 1 mM CaCl 2 , 2 mM MgCl 2 , pH 7.0) was incubated with 0.1 nmol/ 0.32 cm 2 of plate-coated cholesterol. Bound protein was detected with anti-hIgG-HRP followed by the addition of colorimetric substrate. Peroxidase activity was measured by spectrophotometer.
DNA Microarray-Total RNA was isolated by RNeasy (Qiagen). DNA microarray analysis was performed using the Human Gene 1.0 ST array (Affymetrix). Quantitative PCR-Total RNA was isolated by Sepasol-RNA I Super G (Nacalai Tesque). 1 g of RNA sample was used for reverse transcription and synthesis of cDNA with ReverTra Ace qPCR RT Master Mix (TOYOBO). Real-time PCR was performed by using THUNDERBIRD SYBR qPCR mix (TOYOBO) and ABI PRISM 7000 (Applied Biosystems). All primers for specific target genes are listed in Table 1 .
Molecular Simulation-Docking studies of the cholesterol and hMincle were performed by the MOE (Molecular Operating Environment) software using hMincle co-crystallized with citrate (Protein Data Bank (PDB) ID: 3WH2) as a template.
Statistical Analysis-An unpaired two-tailed Student's t test was used for all the statistical analyses.
Results

Identification of Cholesterol as an Endogenous Ligand of
Mincle-To investigate whether hMincle recognizes endogenous lipids, we first separated lipid extracts of liver into 20 frac- tions by silica gel column chromatography and evaluated each fraction using an NFAT-GFP reporter assay. Reporter cells transfected with FcR␥ alone or together with hMincle were stimulated with each fraction in plate-coated form. Activity from these fractions showed a strong peak in Fraction #7 (Fig.   1A ). We then analyzed Fraction #7 by means of HPTLC, separating it into 20 subfractions. Reporter cells expressing hMincle selectively responded to Fraction #7-15 with relatively high R f values (Fig. 1B) , suggesting that hMincle binds to low polarity lipid(s). Further analyses by HPLC and mass spectrometry revealed that the major component of Fraction #7-15 is cholesterol (Fig. 1, C and D) . The cholesterol structure was also confirmed by GC-MS after esterification using TMS (Fig. 1E) . Indeed, purified cholesterol in plate-coated and crystalized forms activated reporter cells expressing hMincle (Fig. 1F) . We further confirmed that hMincle directly binds to coated cholesterol by using soluble hMincle-Ig fusion protein (Fig. 1G) . Collectively, these results suggest that hMincle is capable of interacting with cholesterol crystals.
Human Mincle Selectively Binds to Cholesterol-We next investigated whether hMincle recognizes other lipids. To compare the ligand activity of lipids having different properties under the same conditions, we stimulated reporter cells with plate-bound forms of various lipids. However, none of 68 fatty acids tested was able to induce NFAT activation (Fig. 2) .
Natural steroid hormones are synthesized from cholesterol, and their core structures are similar to that of cholesterol (Fig.   3A) . We therefore asked whether hMincle and mMincle recognize plate-coated steroid hormones. Of note, only cholesterol, but not cortisone, progesterone, estradiol, testosterone, aldosterone, and DHEA, showed ligand activity of hMincle but not mMincle (Fig. 3B) .
Most ingested cholesterol is present in the esterified form; however, cholesterol esters with various lengths of saturated fatty acids had no activity in this assay (Fig. 3C) . The fungal sterol, ergosterol, also had no activity when tested, whereas sitosterol, a plant sterol, and desmosterol, an intermediate of cholesterol synthesis, showed substantial activity with hMincle (Fig. 3D) . Thus, among various steroids, hMincle selectively binds to cholesterol and closely related sterols. These results also suggest that a hydroxyl residue at C3 and an alkyl chain at C17 appear to be required for recognition by hMincle (Fig. 3A) .
Receptor Specificity for Cholesterol Crystals among C-type Lectin Receptors-Mincle and MCL (also called Clec4d or Clecsf8), but not other CLRs, have a patch of hydrophobic amino acids that may be responsible for binding the lipid moiety of TDM (24 -26) . We therefore assessed whether MCL interacts with cholesterol crystals using MCL-expressing reporter cells and found that it did not (Fig. 4A ). In addition, none of the other CLRs closely related to Mincle, such as Dectin-1 and Dectin-2, recognized cholesterol crystals (Fig. 4B) .
We also examined the capability of Mincle from different species to bind cholesterol crystals. Human Mincle responded to cholesterol crystals, whereas mouse and rat Mincle did not (Fig. 4C) . Taken together, among ITAM-coupled CLRs expressed in mammals, human Mincle can uniquely interact with cholesterol crystals.
hMincle Confers Murine Macrophages with Sensitivity to Cholesterol Crystals-To identify cellular responses triggered by the hMincle-cholesterol interaction in myeloid cells, we examined production of proinflammatory cytokines, as these outcomes are independent of inflammasome activation (27) . Consistent with the fact that mMincle did not recognize cholesterol, murine macrophage Raw cells, which express mMincle and functional FcR␥ signaling pathway, were not activated by cholesterol crystals as assessed by secretion of pro-inflammatory cytokines. However, upon transfection with hMincle, Raw cells responded to cholesterol crystals by producing TNF and MIP-2 (Fig. 5A) . The secretion of these cytokines was impaired in the presence of anti-hMincle blocking mAb (Fig. 5B) . These results suggest that expression of hMincle in murine myeloid cells confers sensitivity to cholesterol crystals, resulting in proinflammatory responses.
Cholesterol Crystals Induce Transcription of Inflammatory Genes through hMincle-We then examined gene expression in human DCs in response to cholesterol. Human monocyte-derived DCs (hMo-DCs), which express endogenous hMincle, were stimulated with plate-coated cholesterol or cholesterol crystals. Microarray analyses revealed that similar sets of proinflammatory genes including CLRs, chemokines, and cytokines were markedly up-regulated upon stimulation with the coated and crystalized forms of cholesterol (Fig. 6A) . Although cholesterol crystals are known to activate inflammasomes through organelle damages (15, 16), inflammasome activation does not entirely account for the up-regulation in expression of these genes (28) . Indeed, the induction of such genes, CLEC5A, CCL4, CSF1, AREG, and DCSTAMP, was impaired in the presence of anti-hMincle mAb (Fig. 6B) . These results suggest that cholesterol crystals activate human DCs to induce pro-inflammatory molecules through Mincle. Cholesterol crystals were reported to induce mature IL-1␤ production through inflammasome activation (15) (16) (17) (18) . We then examined the role of hMincle in this process. hMo-DCs produced IL-1␤ by the stimulation with cholesterol crystals in the presence of LPS; however, this was substantially inhibited by anti-hMincle mAb (Fig.   6C, left) . In contrast, anti-hMincle mAb did not affect IL-1␤ secretion induced by another inflammasome activator, monosodium urate crystals (Fig. 6C, right) , which did not bind hMincle (data not shown). These results suggest that the interaction of hMincle with cholesterol crystals contributes to the secretion of mature IL-1␤.
hMincle Binds to Cholesterol Crystals through Its Cholesterolinteracting Motif-It has been reported that several proteins interact with cholesterol through a cholesterol recognition/interaction amino acid consensus (CRAC) motif ((L/V)X 1-5 YX 1-FIGURE 5. Interaction of hMincle with cholesterol crystals induces the production of pro-inflammatory cytokines. A, RAW-Blue cells expressing hMincle or parental cell lines were stimulated with cholesterol crystals, LPS (10 ng/ml), or TDM (100 ng/well). Supernatants were collected after 24 h of culture. Concentrations of TNF and MIP-2 were determined by ELISA. B, RAW-Blue cells expressing hMincle were stimulated with cholesterol crystals (100 g/ml), LPS (10 ng/ml), or TDM (100 ng/ml) for 24 h in the presence or absence of the indicated amount of anti-hMincle antibody (anti-hMincle) or isotype control antibody (R3-34) (control mAb). Concentrations of TNF and MIP-2 were determined by ELISA. All data are representative of two independent experiments and presented as mean Ϯ S.D. *, p Ͻ 0.05. (29 -31) . The particular amino acid sequence matching this motif is found in hMincle (LXY 129 XXXXXR) but not in mMincle (Fig. 7A) . Replacement of Arg in this motif with Leu is known to abolish cholesterol binding (29) . We therefore established reporter cell lines expressing hMincle mutants into which we introduced mutations in the CRAC-like sequence, and then assessed the effect of the mutations on cholesterol recognition ability. Although the mutant in which Arg 135 was replaced with Leu (hMincle R135L ) expressed normally on the cell surface (Fig. 7B) , the hMincle R135L mutant failed to recognize cholesterol crystals (Fig. 7C, left) . Importantly, this mutant retained the ability to recognize TDM at a level comparable with wild-type hMincle (Fig. 7C, right) . These results suggest that the CRAC-like motif within hMincle determines the ability to interact with cholesterol.
5(R/K))
Discussion
In this study, we demonstrate that hMincle directly binds to cholesterol crystals and activates innate immune responses. Cholesterol crystals are metabolic danger signals that trigger NLRP3 inflammasome activation and subsequent IL-1␤ secretion through multiple pathways (15) (16) (17) (18) 32) . hMincle is likely to be involved in IL-1␤ secretion mainly by inducing pro-IL-1␤ (Fig. 6A ) via NF-B activation. Given that ITAM-mediated signals activate NLRP3 in a Syk-dependent manner (33, 34), Mincle may also promote cleavage of pro-IL-1␤ through NLRP3 activation as well as the induction of pro-IL-1␤, as suggested previously (35) (36) (37) . Cholesterol crystals can therefore activate two different families of innate sensors, NLRs and CLRs, which may crosstalk with each other. Indeed, the blockade of hMincle impaired IL-1␤ secretion even in the presence of LPS (Fig. 6C) . Similarly, another inflammatory crystal, monosodium urate, is recognized by both NLRP3 and a CLR, Clec12a (6) . Thus, CLRs may have a tendency to bind to the "crystal form" of endogenous components in addition to recognizing well established carbohydrate-containing compounds. The structural basis and specificity of the recognition of "nonsugar" crystals by CLRs are also important issues to be clarified in the future.
In addition to pro-inflammatory genes, we found that genes related to lipid metabolism were also up-regulated by platecoated and crystal forms of cholesterol (Fig. 6A) . However, the induction of one such gene, lipoprotein lipase (LPL), was not affected by the presence of anti-hMincle. This may suggest the involvement of other cholesterol sensor(s) in DCs that act independently of hMincle.
Cholesterol crystal deposition has been thought to arise at a later phase of atherosclerosis (38) . In contrast, it was recently reported that small cholesterol crystals can be the primary inflammatory stimuli in early atherosclerotic lesions (15) . It therefore remains to be determined whether hMincle initiates inflammation or aggravates already ongoing inflammation in response to cholesterol crystals under pathological conditions. Cholesterol crystals, but not steroid hormones or cholesteryl esters, are recognized by hMincle. Although they have a similar core structure, only cholesterol has a hydrophobic iso-octyl side chain at C-17. We showed that hMincle does not respond to DHEA, which lacks a hydrophobic side chain at C-17 ( Fig. 3B) , suggesting that this side chain might be important for the interaction of cholesterol with hMincle. Despite the existence of the same hydrophobic iso-octyl side chain at C-17, cholesteryl esters did not activate reporter cells. In cholesteryl esters, the 3␤-hydroxyl group at the C-3 position of cholesterol is esterified to a fatty acid. Thus, the 3␤-hydroxyl group may also determine the binding of Mincle to cholesterol. The results from sitosterol, ergosterol, and desmosterol suggest that a single bond between C-7 and C-8 in ring B is required for the activity. Taken together, a steroid backbone with two characteristics, alkyl chain at C-17 and hydroxyl residue at C-3, may be a minimal common feature for binding to hMincle. Alternatively, but not mutually exclusively, as a relatively high concentration of cholesterol crystals is required for the activation of reporter cells, currently we cannot exclude the possibility that a small amount of "modified" cholesterol derivatives or any particular forms of cholesterol crystals may be acting as an active ligand.
To obtain a sufficient amount of candidate lipids, we first used lipid extracts concentrated from bovine liver in this study. We also detected cholesterol as an active ligand from murine liver extract (data not shown). Therefore, a series of procedures of extraction, purification, and identification established in this study may be a useful method to discover novel endogenous ligands (DAMPs) that are released or modified upon damage from various tissues. Besides, this method would be also applicable for identifying de novo-synthesized DAMPs during cellular damages or diseases from damaged tissues or patient samples. The clear species differences between rodents and human imply that Mincle might have acquired reactivity to cholesterol during evolution (Fig. 4C ). In agreement with this assumption, we found that Mincle from various primates and guinea pig has a CRAC consensus sequence at a position corresponding to that of hMincle, whereas neither mouse nor rat Mincle has such sequences (data not shown).
It is still unknown whether ligand recognition through the CRAC consensus sequence results in efficient receptor engagement. According to the simulation based on the crystal structure of hMincle, the CRAC-like sequence appears to form a pocket that is suitable to interact with cholesterol at a different site from that for TDM (data not shown) (24, 26) . These findings suggest that the multivalent form of cholesterol, such as cholesterol crystals or coated cholesterol, could induce multimerization of hMincle in a mechanism similar to multivalent TDM in bacterial cell wall or the plate-coated form (9) (Fig. 8) .
As cholesterol is a highly hydrophobic compound, one might argue that the interaction with hMincle is mediated by aberrant hydrophobic interactions between cholesterol and the hydrophobic portion of the protein. However, we show that other related CLRs did not bind to cholesterol, and hMincle did not interact with other hydrophobic lipid derivatives. Consistent with the fact that cholesterol is normally buried within the physiological membrane, reporter cells expressing hMincle were not activated by interacting with adjacent cells unless crystalized forms were added. Furthermore, the addition of liposomes containing cholesterol or LDLs did not activate reporter cells (data not shown). The specific recognition of cholesterol crystal by hMincle implies that hMincle is involved in a wide variety of physiological and pathological responses induced by cholesterol crystals. As murine Mincle did not interact with cholesterol, more detailed studies are needed to address this issue by establishing humanized animal models, such as hMincle knock-in mice.
To the best of our knowledge, human Mincle is the first surface PRR to be demonstrated to recognize cholesterol crystals and activate innate immunity. As excessive cholesterol and its crystals are closely related to various metabolic disorders and chronic inflammation, this finding may indicate the blockade of human Mincle as a possible therapeutic option in such diseases.
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